These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Intestinal failure-associated liver disease: management and treatment strategies past, present, and future. Carter BA; Karpen SJ Semin Liver Dis; 2007 Aug; 27(3):251-8. PubMed ID: 17682972 [TBL] [Abstract][Full Text] [Related]
4. Prediction, identification and progression of histopathological liver disease activity in children with intestinal failure. Mutanen A; Lohi J; Merras-Salmio L; Koivusalo A; Pakarinen MP J Hepatol; 2021 Mar; 74(3):593-602. PubMed ID: 33002568 [TBL] [Abstract][Full Text] [Related]
5. Current Insights Regarding Intestinal Failure-Associated Liver Disease (IFALD): A Narrative Review. Zafirovska M; Zafirovski A; Rotovnik Kozjek N Nutrients; 2023 Jul; 15(14):. PubMed ID: 37513587 [TBL] [Abstract][Full Text] [Related]
6. Clinical approach to the management of Intestinal Failure Associated Liver Disease (IFALD) in adults: A position paper from the Home Artificial Nutrition and Chronic Intestinal Failure Special Interest Group of ESPEN. Lal S; Pironi L; Wanten G; Arends J; Bozzetti F; Cuerda C; Joly F; Kelly D; Staun M; Szczepanek K; Van Gossum A; Schneider SM; Clin Nutr; 2018 Dec; 37(6 Pt A):1794-1797. PubMed ID: 30017241 [TBL] [Abstract][Full Text] [Related]
11. New insights into intestinal failure-associated liver disease in adults: A comprehensive review of the literature. Fousekis FS; Mitselos IV; Christodoulou DK Saudi J Gastroenterol; 2021; 27(1):3-12. PubMed ID: 33642350 [TBL] [Abstract][Full Text] [Related]
15. Prevention and Treatment of Intestinal Failure-Associated Liver Disease in Children. Norsa L; Nicastro E; Di Giorgio A; Lacaille F; D'Antiga L Nutrients; 2018 May; 10(6):. PubMed ID: 29882922 [TBL] [Abstract][Full Text] [Related]
16. Reversal of intestinal failure-associated liver disease in infants and children on parenteral nutrition: experience with 93 patients at a referral center for intestinal rehabilitation. Cowles RA; Ventura KA; Martinez M; Lobritto SJ; Harren PA; Brodlie S; Carroll J; Jan DM J Pediatr Surg; 2010 Jan; 45(1):84-7; discussion 87-8. PubMed ID: 20105585 [TBL] [Abstract][Full Text] [Related]
17. Assessment of Intestinal Failure Associated Liver Disease according to different diagnostic criteria. Sasdelli AS; Agostini F; Pazzeschi C; Guidetti M; Lal S; Pironi L Clin Nutr; 2019 Jun; 38(3):1198-1205. PubMed ID: 29778510 [TBL] [Abstract][Full Text] [Related]
18. Intestinal failure-associated liver disease in hospitalised children. Pichler J; Horn V; Macdonald S; Hill S Arch Dis Child; 2012 Mar; 97(3):211-4. PubMed ID: 22247247 [TBL] [Abstract][Full Text] [Related]
20. The role of parenteral lipids in the development of advanced intestinal failure-associated liver disease in infants: a multiple-variable analysis. Diamond IR; de Silva NT; Tomlinson GA; Pencharz PB; Feldman BM; Moore AM; Ling SC; Wales PW JPEN J Parenter Enteral Nutr; 2011 Sep; 35(5):596-602. PubMed ID: 21825088 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]